Literature DB >> 17495642

The impact of luteinizing hormone in assisted reproduction: a review.

Andrea Weghofer1, Sarah Schnepf, David Barad, Norbert Gleicher.   

Abstract

PURPOSE OF REVIEW: Although the key role of luteinizing hormone in ovarian function, the promotion of follicular growth and maturation, is widely acknowledged, its usefulness as a predictor of ovarian status, and as a supplement during fertility treatment, remains controversial. RECENT
FINDINGS: Luteinizing hormone alone is not an effective predictor of ovarian function. In combination with follicle-stimulating hormone, as the so-called follicle-stimulating hormone: luteinizing hormone ratio, it serves as a useful marker of ovarian status. Although published data on luteinizing hormone supplementation during ovarian hyperstimulation are somewhat limited, recent well-designed studies suggest a beneficial effect of: (1) luteinizing hormone supplementation for women with inadequate responses to follicle-stimulating hormone-only stimulation; (2) in primarily young patients with low baseline luteinizing hormone levels and, consequently, insufficient remaining endogenous luteinizing hormone concentration during pituitary suppression; and (3) in older women with higher baseline luteinizing hormone levels and age-appropriate ovarian function, who require higher luteinizing hormone thresholds, even during pituitary suppression.
SUMMARY: Luteinizing hormone levels, as a component of the follicle-stimulating hormone: luteinizing hormone ratio, contribute to the assessment of ovarian function, whereas the supplementation of luteinizing hormone on an individualized basis, in carefully selected patients, improves outcomes of ovarian stimulation with gonadotropins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495642     DOI: 10.1097/GCO.0b013e3280bad843

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  5 in total

1.  Effects of Low Luteinizing Hormone During Ovarian Stimulation on Endometrial Gene Expression and Function - Transcriptome Analysis During the Implantation Window.

Authors:  Shuo Han; Ming-Hui Liu; Ya-Su Lv; Hai-Ying Ren; Jing Guo; Yuan Li; Shan Liu
Journal:  Reprod Sci       Date:  2022-02-15       Impact factor: 3.060

2.  Research and experimental verification of the molecular mechanism of berberine in improving premature ovarian failure based on network pharmacology.

Authors:  Wu Xue; Fan Xue; Tao Jia; Ai Hao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study.

Authors:  Yue Lin; Qianqian Chen; Jing Zhu; Yili Teng; Xuefeng Huang; Xia Chen
Journal:  Drug Des Devel Ther       Date:  2021-12-21       Impact factor: 4.162

4.  FSH in vitro versus LH in vivo: similar genomic effects on the cumulus.

Authors:  Mourad Assidi; François J Richard; Marc-André Sirard
Journal:  J Ovarian Res       Date:  2013-09-25       Impact factor: 4.234

Review 5.  Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers.

Authors:  Zehra Jamil; Syeda Sadia Fatima; Khalid Ahmed; Rabia Malik
Journal:  Dis Markers       Date:  2016-02-10       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.